[Psychosis, visual hallucinations and worsening renal function due to a gabapentine-morphine interaction].
Borobia-Perez
A M
AM
Servicio de Farmacología Clínica, Hospital Universitario La Paz, Madrid, Spain. a.borobia@gmail.com
Fernandez-Capitan
C
C
Carcas-Sansuan
A J
AJ
D000369:Aged, 80 and over; D000588:Amines / Q000494:pharmacology / Q000627:therapeutic use; D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology / Q000627:therapeutic use; D004347:Drug Interactions; D005260:Female; D000077206:Gabapentin; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000502:physiology; D009020:Morphine / Q000494:pharmacology / Q000627:therapeutic use; D009294:Narcotics / Q000494:pharmacology / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D011618:Psychotic Disorders / Q000503:physiopathology*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology / Q000627:therapeutic use
D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D009294:Narcotics; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D009020:Morphine